In the BioHarmony Drug Report Database

"Preview" Icon

Pretomanid

Pretomanid, Dovprela, Pretomanid FGK (pretomanid) is a small molecule pharmaceutical. Pretomanid was first approved as Pretomanid on 2019-08-14. It is used to treat extensively drug-resistant tuberculosis in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis.

 

Trade Name

 

Dovprela, Pretomanid FGK
 

Common Name

 

pretomanid
 

ChEMBL ID

 

CHEMBL227875
 

Indication

 

extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis
 

Drug Class

 

Mycolic acid inhibitors

Image (chem structure or protein)

Pretomanid structure rendering